|
Odyssey Thera researches new treatments for cancer and rheumatoid arthritis using its protein-fragment complementation assays (PCAs) to observe the action of small molecules and proteins. Essentially, it works to improve the speed and predictability of the drugs it studies. It technologies expedite the discovery and uses of drugs as well as track the development of new drug therapies. Odyssey partners with large drug makers such as Roche and Pfizer to profile selected compounds across its panel of assays to identify potential lead drug candidates. In 2005 it partnered with Bristol-Myers Squibb to analyze its compounds.
|
| | | Contact Information | |
Address: |
4550 Norris Canyon Rd., Ste. 140
San Ramon, CA 94583
| | Phone: | 925-242-5000 | | Fax: | 925-242-1936 |
|
| Financial
Highlights | | Revenue (2007): | 5.80 M | | Employees (2007): | 30 |
|
|
Key People
| | • |
Chairman:
Hugh Y. Rienhoff Jr.
| | • |
President, CEO, and Chief Scientific Officer:
John K. Westwick
|
|
|
